Appeals court rules for FTC on HSR rulemaking on pharmaceuticals

A three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit ruled that the Federal Trade Commission was within its rights to write rules targeting a specific...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:

FTCWatch is delivered in the following formats: via email alert and online at